| Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder TM Gates, LA Cysique, KJ Siefried, J Chaganti, KJ Moffat, BJ Brew Aids 30 (4), 591-600, 2016 | 117 | 2016 |
| HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research LA Cysique, RK Heaton, J Kamminga, T Lane, TM Gates, DM Moore, ... Journal of neurovirology 20, 258-268, 2014 | 87 | 2014 |
| Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity C Gott, T Gates, N Dermody, BJ Brew, LA Cysique PloS one 12 (3), e0171887, 2017 | 71 | 2017 |
| The chronicity of HIV infection should drive the research strategy of NeuroHIV treatment studies: a critical review TM Gates, LA Cysique CNS drugs 30 (1), 53-69, 2016 | 61 | 2016 |
| Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression KJ Siefried, L Mao, S Kerr, LA Cysique, TM Gates, J McAllister, A Maynard, ... PLoS One 12 (4), e0174613, 2017 | 54 | 2017 |
| Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection MJ Nichols, TM Gates, JR Soares, KJ Moffat, CD Rae, BJ Brew, ... Aids 33 (1), 55-66, 2019 | 46 | 2019 |
| Functional connectivity in virally suppressed patients with HIV-associated neurocognitive disorder: a resting-state analysis JR Chaganti, A Heinecke, TM Gates, KJ Moffat, BJ Brew American Journal of Neuroradiology 38 (8), 1623-1629, 2017 | 46 | 2017 |
| Catecholamines and paroxysmal sympathetic hyperactivity after traumatic brain injury JF Fernandez-Ortega, IJ Baguley, TA Gates, M Garcia-Caballero, ... Journal of Neurotrauma 34 (1), 109-114, 2017 | 45 | 2017 |
| Imaging correlates of the blood–brain barrier disruption in HIV-associated neurocognitive disorder and therapeutic implications J Chaganti, K Marripudi, LP Staub, CD Rae, TM Gates, KJ Moffat, BJ Brew Aids 33 (12), 1843-1852, 2019 | 41 | 2019 |
| Covertly active and progressing neurochemical abnormalities in suppressed HIV infection LA Cysique, L Jugé, T Gates, M Tobia, K Moffat, BJ Brew, C Rae Neurology: Neuroimmunology & Neuroinflammation 5 (1), e430, 2018 | 24 | 2018 |
| Elevation of cell-associated HIV-1 transcripts in CSF CD4+ T cells, despite effective antiretroviral therapy, is linked to brain injury K Suzuki, J Zaunders, TM Gates, A Levert, S Butterly, Z Liu, T Ishida, ... Proceedings of the National Academy of Sciences 119 (48), e2210584119, 2022 | 19 | 2022 |
| How all-type dementia risk factors and modifiable risk interventions may be relevant to the first-generation aging with HIV infection? HL Aung, S Kootar, TM Gates, BJ Brew, LA Cysique European Geriatric Medicine 10, 227-238, 2019 | 18 | 2019 |
| Age‐related trends in late mortality following traumatic brain injury: a multicentre inception cohort study MT Nott, TM Gates, IJ Baguley Australasian journal on ageing 34 (2), E1-E6, 2015 | 17 | 2015 |
| Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not HL Aung, KJ Siefried, TM Gates, BJ Brew, L Mao, A Carr, LA Cysique EClinicalMedicine 56, 2023 | 14 | 2023 |
| HIV brain latency as measured by CSF BcL11b relates to disrupted brain cellular energy in virally suppressed HIV infection LA Cysique, L Jugé, MJ Lennon, TM Gates, SP Jones, MD Lovelace, ... Aids 33 (3), 433-441, 2019 | 14 | 2019 |
| Cognitive ageing is premature among a community sample of optimally treated people living with HIV HL Aung, M Bloch, T Vincent, D Quan, A Jayewardene, Z Liu, TM Gates, ... HIV medicine 22 (3), 151-164, 2021 | 12 | 2021 |
| An examination of reliable change methods for measuring cognitive change with the Cogstate Computerized Battery: Research and clinical implications TM Gates, J Kamminga, A Jayewardene, T Vincent, D Quan, BJ Brew, ... Archives of Clinical Neuropsychology 36 (4), 597-612, 2021 | 11 | 2021 |
| Lack of cognitive impairment in long-term survivors of colorectal cancer JL Vardy, GR Pond, LA Cysique, TM Gates, J Lagopoulos, C Renton, ... Supportive Care in Cancer 30 (7), 6123-6133, 2022 | 10 | 2022 |
| External causes of death after severe traumatic brain injury in a multicentre inception cohort: clinical description and risk factors TM Gates, IJ Baguley, MT Nott, GK Simpson Brain injury 33 (7), 821-829, 2019 | 6 | 2019 |
| A vocational intervention that enhances return to work after severe acquired brain injury: A pragmatic trial GK Simpson, P McRae, TM Gates, M Daher, D Johnston, ID Cameron Annals of physical and rehabilitation medicine 66 (8), 101787, 2023 | 4 | 2023 |
